Home
Live Updates
Patients With Newly Diagnosed, High-Risk Myeloma See High MRD Negative Rates With Isa-KRd : comparemela.com
Patients With Newly Diagnosed, High-Risk Myeloma See High MRD Negative Rates With Isa-KRd
Treatment with the combination of Sarclisa, Kyprolis, Revlimid and Isa-KRd generated high rates of minimal residual disease negativity in patients with newly diagnosed, high-risk multiple myeloma, irrespective of transplant status.
Related Keywords
Hamburg ,
Germany ,
Boston ,
Massachusetts ,
United States ,
Eppendorf ,
Nordrhein Westfalen ,
Dana Farber Cancer Institute ,
Lisa Leypoldt ,
University Medical Center Hamburg ,
International Myeloma Society Annual Meeting ,
Harvard Medical School ,
Myeloma Society Annual Meeting ,
University Medical Center Hamburg Eppendorf ,
Second Revision ,
Myeloma ,
comparemela.com © 2020. All Rights Reserved.